Influential Scientific Information
As part of releasing NNCSS’s initial multiple sclerosis (MS) and Parkinson’s disease (PD) prevalence estimates, CDC has produced two technical reports—one each for MS and PD—that describe the methods used to identify cases (i.e., people with the disease) within data sources available to CDC for national surveillance, and that present national prevalence estimates for 2019 by select demographic and geographic characteristics.
This web page provides information on the independent peer review of these NNCSS technical reports that have been defined as Influential Scientific Information (ISI). CDC makes this information available to demonstrate its efforts to utilize only the most transparent and independent peer review, appropriate research methods, and the highest level of data quality. In addition, this information demonstrates the program’s compliance with the specific requirements of the Information Quality Act (2000), 44 U.S.C. §3516, and of peer-review standards developed by the Office of Management and Budget (OMB), the U.S. Department of Health and Human Services (DHHS), and CDC. The OMB requirements, described in this White House memo, include making publicly available specific information on the peer review of influential documents disseminated by the federal government.
For issues related to NNCSS Technical Reports included in CDC’s Peer Review Agenda please contact:
National Neurological Conditions Surveillance System
Centers for Disease Control and Prevention
1600 Clifton Road, NE MS V24-6
Atlanta, GA 30329
NNCSSsupport@CDC.gov
NNCSS Technical Report: Parkinson’s Disease Prevalence Estimates among Adults Aged 35 and Older, United States, 2019
NNCSS will post the following as they become available: Technical Report, Summarized Peer Reviewer Commentary, Responses to Commentary.
NNCSS Technical Report: Multiple Sclerosis Prevalence Estimates among Adults Aged 18 and Older, United States, 2019
NNCSS will post the following as they become available: Technical Report, Summarized Peer Reviewer Commentary, Responses to Commentary.